ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026
Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross-sectional comparative echocardiographic study.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross-sectional comparative echocardiographic study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveWhile cardiometabolic comorbidities have been well established in adults with polycystic ovary syndrome (PCOS), it remains unclear whether the early signs of cardiovascular morbidity emerge during adolescence. This study aimed to investigate whether metabolic and cardiovascular alterations begin in adolescents with PCOS.
methodsThe study included adolescents with PCOS and age and body mass index (BMI, calculated as weight in kilograms divided by the square of height in meters) matched healthy controls who were further grouped based on weight status as overweight/obese and normal weight. All participants underwent metabolic assessment through physical examination, laboratory tests, conventional echocardiography, tissue Doppler imaging, strain echocardiography, and 24-h Holter monitoring.
resultsThe PCOS group (n = 33) consisted of 19 overweight/obese and 14 normal-weight participants, while the control group (n = 43) included 20 overweight/obese and 23 normal-weight participants. Compared to controls, the PCOS group exhibited higher waist-to-hip ratio, liver enzymes, triglycerides, triglyceride-glucose index, and lower high-density lipoprotein cholesterol (P < 0.05). Among BMI subgroups, overweight/obese PCOS group had the highest insulin and homeostasis model assessment of insulin resistance levels compared to all other groups. The PCOS group showed higher left atrial (LA) end-systolic diameter, LA/aortic ratio, and lower left ventricular global peak longitudinal strain in the apical four-chamber view than controls (P < 0.05). Among BMI subgroups, the combination of PCOS and overweight/obesity was associated with the most unfavorable metabolic and cardiovascular profiles. The markers of LA diameter, LA/aortic ratio, and left ventricular mass were highest in the overweight/obese PCOS group.
conclusionSelected metabolic and echocardiographic markers showed modest differences when PCOS coexisted with obesity, suggesting a potentially higher cardiometabolic risk compared with PCOS or obesity alone. Early identification and targeted management are essential to mitigate long-term cardiometabolic complications in this high-risk group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.